SEARCH

SEARCH BY CITATION

References

  • Andoh, A, Hirashima, M, Maeda, H, Hata, K, Inatomi, O, Tsujikawa, T, Sasaki, M, Takahashi, K & Fujiyama, Y (2005) Serum selenoprotein-P levels in patients with inflammatory bowel disease. Nutrition, 21, 574579.
  • Angstwurm, MW, Engelmann, L, Zimmermann, T, Lehmann, C, Spes, CH, Abel, P, Strauss, R, Meier-Hellmann, A, Insel, R, Radke, J, Schuttler, J & Gartner, R (2007) Selenium in intensive care (SIC): results of a prospective randomized, placebo-controlled, multiple-center study in patients with severe systemic inflammatory response syndrome, sepsis, and septic shock. Critical care medicine, 35, 118126.
  • Asfour, IA, El- Kholy, NM, Ayoub, MS, Ahmed, MB & Bakarman, AA (2009) Selenium and glutathione peroxidase status in adult Egyptian patients with acute myeloid leukemia. Biological Trace Element Research, 132, 8592.
  • Avanzini, P, Vinceti, M, Ilariucci, F, Masini, L, D’Inca, M & Vivoli, G (1995) Serum selenium concentrations in patients with newly diagnosed lymphoid malignancies. Haematologica, 80, 505511.
  • Beguin, Y, Weber, G, Delbrouck, JM, Roelandts, I, Robaye, G, Bury, J & Fillet, G (1986) Serum trace elements during chemotherapy for acute myelogenous leukemia. Acta Pharmacologica et Toxicologica (Copenh), 59(Suppl. 7), 270273.
  • Beguin, Y, Brasseur, F, Weber, G, Bury, J, Delbrouck, JM, Roelandts, I, Robaye, G & Fillet, G (1987) Observations of serum trace elements in chronic lymphocytic leukemia. Cancer, 60, 18421846.
  • Beguin, Y, Bours, V, Delbrouck, JM, Robaye, G, Roelandts, I, Bury, J, Fillet, G & Weber, G (1989) Relationship of serum selenium levels to tumor activity in acute non-lymphocytic leukemia. Carcinogenesis, 10, 20892091.
  • Bennett, JM, Catovsky, D, Daniel, MT, Flandrin, G, Galton, DA, Gralnick, HR & Sultan, C (1976) Proposals for the classification of the acute leukaemias. French–American–British (FAB) co-operative group. British Journal of Haematology, 33, 451458.
  • van Besien, K, Sobocinski, KA, Rowlings, PA, Murphy, SC, Armitage, JO, Bishop, MR, Chaekal, OK, Gale, RP, Klein, JP, Lazarus, HM, McCarthy, Jr, PL, Raemaekers, JM, Reiffers, J, Phillips, GL, Schattenberg, AV, Verdonck, LF, Vose, JM & Horowitz, MM (1998) Allogeneic bone marrow transplantation for low-grade lymphoma. Blood, 92, 18321836.
  • Brenner, DA, Buck, M, Feitelberg, SP & Chojkier, M (1990) Tumor necrosis factor-alpha inhibits albumin gene expression in a murine model of cachexia. Journal of Clinical Investigation, 85, 248255.
  • Cao, S, Durrani, FA & Rustum, YM (2004) Selective modulation of the therapeutic efficacy of anticancer drugs by selenium containing compounds against human tumor xenografts. Clinical Cancer Research, 10, 25612569.
  • Charalabopoulos, K, Kotsalos, A, Batistatou, A, Charalabopoulos, A, Vezyraki, P, Peschos, D, Kalfakakou, V & Evangelou, A (2006) Selenium in serum and neoplastic tissue in breast cancer: correlation with CEA. British Journal of Cancer, 95, 674676.
  • Clark, LC, Combs, Jr, GF, Turnbull, BW, Slate, EH, Chalker, DK, Chow, J, Davis, LS, Glover, RA, Graham, GF, Gross, EG, Krongrad, A, Lesher, Jr, JL, Park, HK, Sanders, Jr, BB, Smith, CL & Taylor, JR (1996) Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional prevention of cancer study group. JAMA, 276, 19571963.
  • Deffuant, C, Celerier, P, Boiteau, HL, Litoux, P & Dreno, B (1994) Serum selenium in melanoma and epidermotropic cutaneous T-cell lymphoma. Acta Dermato Venereologica, 74, 9092.
  • Delves, T & Sieniawska, C (1997) Simple method for the analysis of accurate determination of selenium in serum, using ICP-MS. Journal of Analytical Atomic Spectrometry, 12, 387389.
  • Duffield- Lillico, AJ, Dalkin, BL, Reid, ME, Turnbull, BW, Slate, EH, Jacobs, ET, Marshall, JR & Clark, LC (2003) Selenium supplementation, baseline plasma selenium status and incidence of prostate cancer: an analysis of the complete treatment period of the nutritional prevention of cancer trial. BJU International, 91, 608612.
  • El-Bayoumy, K (2001) The protective role of selenium on genetic damage and on cancer. Mutation Research, 475, 123139.
  • Forceville, X, Vitoux, D, Gauzit, R, Combes, A, Lahilaire, P & Chappuis, P (1998) Selenium, systemic immune response syndrome, sepsis, and outcome in critically ill patients. Critical Care Medicine, 26, 15361544.
  • Hollenbach, B, Morgenthaler, NG, Struck, J, Alonso, C, Bergmann, A, Kohrle, J & Schomburg, L (2008) New assay for the measurement of selenoprotein P as a sepsis biomarker from serum. Journal of Trace Elements in Medicine and Biology, 22, 2432.
  • Hu, YJ, Chen, Y, Zhang, YQ, Zhou, MZ, Song, XM, Zhang, BZ, Luo, L, Xu, PM, Zhao, YN, Zhao, YB & Cheng, G (1997) The protective role of selenium on the toxicity of cisplatin-contained chemotherapy regimen in cancer patients. Biological Trace Element Research, 56, 331341.
  • Ip, C, Thompson, HJ, Zhu, Z & Ganther, HE (2000) In vitro and in vivo studies of methylseleninic acid: evidence that a monomethylated selenium metabolite is critical for cancer chemoprevention. Cancer Research, 60, 28822886.
  • Jaffe, ES, Harris, NL, Stein, H & Vardiman, JW. (2001) World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. IARC Press, London, UK.
  • Johnson, PW, Rohatiner, AZ, Whelan, JS, Price, CG, Love, S, Lim, J, Matthews, J, Norton, AJ, Amess, JA & Lister, TA (1995) Patterns of survival in patients with recurrent follicular lymphoma: a 20-year study from a single center. Journal of Clinical Oncology, 13, 140147.
  • Juliger, S, Goenaga-Infante, H, Lister, TA, Fitzgibbon, J & Joel, SP (2007) Chemosensitization of B-cell lymphomas by methylseleninic acid involves nuclear factor-kappaB inhibition and the rapid generation of other selenium species. Cancer Research, 67, 1098410992.
  • Last, KW, Cornelius, V, Delves, T, Sieniawska, C, Fitzgibbon, J, Norton, A, Amess, J, Wilson, A, Rohatiner, AZ & Lister, TA (2003) Presentation serum selenium predicts for overall survival, dose delivery, and first treatment response in aggressive non-Hodgkin’s lymphoma. Journal of Clinical Oncology, 21, 23352341.
  • Last, K, Maharaj, L, Perry, J, Strauss, S, Fitzgibbon, J, Lister, TA & Joel, S (2006) The activity of methylated and non-methylated selenium species in lymphoma cell lines and primary tumours. Annals of Oncology, 17, 773779.
  • Lippman, SM, Klein, EA, Goodman, PJ, Lucia, MS, Thompson, IM, Ford, LG, Parnes, HL, Minasian, LM, Gaziano, JM, Hartline, JA, Parsons, JK, Bearden, 3rd, JD, Crawford, ED, Goodman, GE, Claudio, J, Winquist, E, Cook, ED, Karp, DD, Walther, P, Lieber, MM, Kristal, AR, Darke, AK, Arnold, KB, Ganz, PA, Santella, RM, Albanes, D, Taylor, PR, Probstfield, JL, Jagpal, TJ, Crowley, JJ, Meyskens, Jr, FL, Baker, LH & Coltman, Jr, CA. (2009) Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the selenium and vitamin E cancer prevention trial (SELECT). JAMA, 301, 3951.
  • Maehira, F, Luyo, GA, Miyagi, I, Oshiro, M, Yamane, N, Kuba, M & Nakazato, Y (2002) Alterations of serum selenium concentrations in the acute phase of pathological conditions. Clinica Chimica Acta, 316, 137146.
  • Meplan, C, Crosley, LK, Nicol, F, Beckett, GJ, Howie, AF, Hill, KE, Horgan, G, Mathers, JC, Arthur, JR & Hesketh, JE (2007) Genetic polymorphisms in the human selenoprotein P gene determine the response of selenoprotein markers to selenium supplementation in a gender-specific manner (the SELGEN study). FASEB Journal, 21, 30633074.
  • Meyer, HA, Hollenbach, B, Stephan, C, Endermann, T, Morgenthaler, NG, Cammann, H, Kohrle, J, Jung, K & Schomburg, L (2009) Reduced serum selenoprotein P concentrations in German prostate cancer patients. Cancer Epidemiology, Biomarkers and Prevention, 18, 23862390.
  • Moschos, MP (2000) Selenoprotein P. Cellular and Molecular Life Sciences, 57, 18361845.
  • Ozgen, IT, Dagdemir, A, Elli, M, Saraymen, R, Pinarli, FG, Fisgin, T, Albayrak, D & Acar, S (2007) Hair selenium status in children with leukemia and lymphoma. Journal of Pediatric Hematology/Oncology, 29, 519522.
  • Renko, K, Hofmann, PJ, Stoedter, M, Hollenbach, B, Behrends, T, Kohrle, J, Schweizer, U & Schomburg, L (2009) Down-regulation of the hepatic selenoprotein biosynthesis machinery impairs selenium metabolism during the acute phase response in mice. FASEB Journal, 23, 17581765.